GPCR
Structure Therapeutics Inc - ADR

2,077
Mkt Cap
$3.44B
Volume
909,013.00
52W High
$94.90
52W Low
$13.22
PE Ratio
-19.77
GPCR Fundamentals
Price
$48.59
Prev Close
$50.46
Open
$50.07
50D MA
$71.72
Beta
0.88
Avg. Volume
933,419.40
EPS (Annual)
-$2.39
P/B
2.27
Rev/Employee
$0.00
$2,677.55
Loading...
Loading...
News
all
press releases
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
Key PointsB Group acquired 90,000 shares of Structure Therapeutics in the fourth quarter...
Nasdaq News: Markets·8h ago
News Placeholder
More News
News Placeholder
Structure Therapeutics (NASDAQ:GPCR) Shares Down 7.5% - Should You Sell?
Structure Therapeutics (NASDAQ:GPCR) Trading Down 7.5% - Should You Sell...
MarketBeat·4d ago
News Placeholder
Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?
LLY stock falls 6% after an HSBC downgrade flagged persisting U.S. pricing pressure, rising market competition and compounded tirzepatide risks, despite strong GLP-1 demand.
Zacks·5d ago
News Placeholder
What is HC Wainwright's Forecast for GPCR FY2027 Earnings?
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) - Stock analysts at HC Wainwright lifted their FY2027 earnings per share (EPS) estimates for Structure Therapeutics in a report...
MarketBeat·5d ago
News Placeholder
Structure Therapeutics Posts 15%+ Weight Loss in ACCESS II for Oral GLP-1 Aleniglipron, Eyes Phase III
Structure Therapeutics (NASDAQ:GPCR) shared new top-line results from its ACCESS II clinical program for aleniglipron, an oral small-molecule GLP-1 receptor agonist being developed for chronic weight...
MarketBeat·5d ago
News Placeholder
Structure Therapeutics (NASDAQ:GPCR) Sees Strong Trading Volume - Still a Buy?
Structure Therapeutics (NASDAQ:GPCR) Sees Strong Trading Volume - Should You Buy...
MarketBeat·6d ago
News Placeholder
Structure Therapeutics (NASDAQ:GPCR) Given New $100.00 Price Target at HC Wainwright
HC Wainwright decreased their target price on shares of Structure Therapeutics from $114.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday...
MarketBeat·6d ago
News Placeholder
HighVista Strategies LLC Acquires 149,615 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR
HighVista Strategies LLC lifted its stake in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) by 172.7% during the 3rd quarter, according to the company in its most recent Form...
MarketBeat·7d ago
News Placeholder
First Light Asset Management LLC Boosts Holdings in Structure Therapeutics Inc. Sponsored ADR $GPCR
First Light Asset Management LLC grew its stake in shares of Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) by 61.5% in the third quarter, according to the company in its most...
MarketBeat·7d ago
News Placeholder
ArrowMark Colorado Holdings LLC Boosts Stock Position in Structure Therapeutics Inc. Sponsored ADR $GPCR
ArrowMark Colorado Holdings LLC raised its position in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) by 8.1% during the 3rd quarter, according to the company in its most...
MarketBeat·7d ago
<
1
2
...
>

Latest GPCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.